Alvogen, Inc. Company Profile

17:44 EST 22nd December 2014 | BioPortfolio

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 130 pharmaceutical products in development and registration with several products expected to be launched in 2010. The product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of Oncology, Cardiology, Respiratory, Neurology and Gastroenterology.


News Articles [11 Associated News Articles listed on BioPortfolio]

Alvogen Acquires Korean Dream Pharma for $187M

Alvogen announced today that it has acquired Dream Pharma in South Korea for $187 million in cash. Dream will be acquired through Alvogen’s Asian subsidiaries and, on completion, will create one of ...

Alvogen acquired Dream Pharma for $187 million

Alvogen has acquired Dream Pharma in South Korea for US$187 million in cash. Dream will be acquired through Alvogen’s Asian subsidiaries and, on completion, will create one of the largest generic ph...

Alvogen To Buy Dream For $187M In APAC Expansion

South Korea's Dream Pharma has agreed to be acquired by Alvogen for $187 million in cash as the U.S.-based generics maker expands its holdings in the Asia-Pacific region.

Alvogen buys South Korean generics drugmaker for $187 mln

Aug 6 (Reuters) - Generic drugmaker Alvogen said it had agreed to buy South Korea's Dream Pharma for $187 million in cash as part of a push into Asia by the fast-growing U.S.-based company.

Alvogen builds on Asian Dream with $187m acquisition

US-based generics company Alvogen has shelled out $187m for its third major acquisition in Asia in two years, scooping up South Korea's Dream Pharma.

Alvogen acquires Korean Dream Pharma for $187 million

Privately-owned US generics firm Alvogen says it has acquired Dream Pharma in South Korea for $187 million in cash, marking the third significant buy for the company since 2012.

Alvogen Acquires SK Firm Dream Pharma For $187M

U.S. based pharmaceutical company Alvogen announced that it has acquired South Korean company Dream Pharma through its subsidiary Kunwha Pharmaceuticals. The transaction will result in the biggest gen...

DreamPharma, Alvogen deal

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen, Inc." on BioPortfolio

We have published hundreds of Alvogen, Inc. news stories on BioPortfolio along with dozens of Alvogen, Inc. Clinical Trials and PubMed Articles about Alvogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen, Inc. Companies in our database. You can also find out about relevant Alvogen, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

Cardiology
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record